Cite
HARVARD Citation
Laight, B. et al. (n.d.). 212P Augmenting cancer immunotherapy by targeting the fes kinase. Immuno-oncology technology. p. . [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Laight, B. et al. (n.d.). 212P Augmenting cancer immunotherapy by targeting the fes kinase. Immuno-oncology technology. p. . [Online].